In a similar manner, high levels of ALKBH3 associated with the poor outcome of patients with pancreatic cancer and renal cell carcinoma [10,12], while the opposite was observed in breast cancer, lung adenocarcinoma and Hodgkin lymphoma [13,14,15]. The gene discussed is ALKBH3; the disease is familial pancreatic carcinoma.